Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vitamin B12 and B6 for Vincristine Induced Peripheral Neuropathy
NCT02923388Phase 4Completed
- Sponsor
- Bangabandhu Sheikh Mujib Medical University
- Start
- Oct 2016
- Primary completion
- Jun 2018
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of mecobalamin and pyridoxine in peripheral neuropathy (2 arms), sponsored by Bangabandhu Sheikh Mujib Medical University. Primary endpoints: Time of onset of Vincristine Induced Peripheral Neuropathy at 5 weeks, Severity of Vincristine Induced Peripheral Neuropathy at 5 weeks and 1 more. Started Oct 2016; status: completed.
02
Drugs
mecobalaminpyridoxine
03
Conditions
peripheral neuropathy
Beyond the preview
Go deeper on NCT02923388.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02923388.